We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

IMPlementation of gUideLines for the Management of Arterial hypertenSION. The IMPULSION Study (IMPULSION)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00416611
First Posted: December 28, 2006
Last Update Posted: January 29, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Hellenic Atherosclerosis Society
  Purpose
The objective of this protocol is to improve awareness, treatment, and control of arterial hypertension, within primary prevention of target organ damage, by implementing guidelines, after training of the participating physicians.

Condition Intervention Phase
High Blood Pressure Behavioral: Implementation of guidelines Phase 4

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: IMPlementation of gUideLines for the Management of Arterial hypertenSION. The IMPULSION Study

Further study details as provided by Hellenic Atherosclerosis Society:

Primary Outcome Measures:
  • Efficacy in arterial hypertension control [ Time Frame: 6 months ]
  • Efficacy in reducing estimated risk of coronary heart disease [ Time Frame: 6 months ]

Secondary Outcome Measures:
  • Cost effectiveness of arterial hypertension control [ Time Frame: 6 months ]
  • Differences between primary and secondary health care settings as well as teaching hospitals [ Time Frame: 6 months ]

Estimated Enrollment: 1000
Study Start Date: November 2006
Study Completion Date: November 2007
Primary Completion Date: November 2007 (Final data collection date for primary outcome measure)
Detailed Description:

Physicians from 20 hospitals and 40 health centres (primary health care settings) were trained to implement guidelines in treating arterial hypertension.

There will be a baseline recording of patients with arterial hypertension and then physicians will have to complete a one page form (by ticking pre-specified boxes) about the baseline status of the patients and will have to report the measures they took to improve awareness, treatment, and effective control of arterial hypertension. After a six month effort, physicians will have to complete the same form at study completion. Previous training of physicians and the fact that they will have to report their success in treating hypertension will hopefully contribute to an increase in number of hypertensive patients at blood pressure target, and will minimise the target organ damage. The estimated reduction in coronary heart disease risk will be evaluated by a comparison of this risk (as evaluated by a risk engine, i.e. PROCAM) at study completion with that of baseline.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Arterial hypertension as defined by the JNC 7 report

Exclusion Criteria:

  • Pregnancy
  • Lactation
  • Malignancies with small life expectancy
  • Unwillingness to participate
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00416611


Locations
Greece
Hellenic Atherosclerosis Society
Thessaloniki, Greece, 55132
Sponsors and Collaborators
Hellenic Atherosclerosis Society
Investigators
Study Director: Athyros G Athyros, MD Clinical Trials Chair of Hellenic Atherosclerosis Society
  More Information

Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Hellenic Atherosclerosios Society, V. Athyros, MD member of Advisdory Board of Hellenic Atherosclerosios Society
ClinicalTrials.gov Identifier: NCT00416611     History of Changes
Other Study ID Numbers: HAS-02-231206
First Submitted: December 23, 2006
First Posted: December 28, 2006
Last Update Posted: January 29, 2009
Last Verified: January 2009

Keywords provided by Hellenic Atherosclerosis Society:
High blood pressure
Awareness
Treatment
Effective Control
Coronary heart disease risk reduction
Hypertension

Additional relevant MeSH terms:
Hypertension
Vascular Diseases
Cardiovascular Diseases